North America Bioanalytical Testing Services Market Report 2022: Growing R&D Expenditure & the Rising Adoption of the Quality by Design (QbD) Driving 8.3% Growth
North American Bioanalytical Testing Services Market
Dublin, Aug. 11, 2022 (GLOBE NEWSWIRE) -- The "North America Bioanalytical Testing Services Market 2021-2031 by Molecule Type, Application, Test Type, Workflow Process, Therapeutic Area, End User, and Country: Trend Forecast and Growth Opportunity" report has been added to ResearchAndMarkets.com's offering.
The North America bioanalytical testing services market is projected to grow by 8.3% annually in the forecast period and reach $3,232.3 million by 2031, driven by the rising demand for analytical testing of biologics and biosimilars amid COVID-19 pandemic, increasing preference for outsourcing analytical testing, growing R&D expenditure in the pharmaceutical and biopharmaceutical industries, and the rising adoption of the Quality by Design (QbD) approach.
In-depth qualitative analyses include identification and investigation of the following aspects:
Market Structure
Growth Drivers
Restraints and Challenges
Emerging Product Trends & Market Opportunities
Porter's Five Forces
The trend and outlook of North America market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify North America bioanalytical testing services market in every aspect of the classification from perspectives of Molecule Type, Application, Test Type, Workflow Process, Therapeutic Area, End User, and Country.
Based on Molecule Type, the North America market is segmented into the following sub-markets with annual revenue ($mn) for 2021-2031 included in each section.
Small Molecules
Large Molecules
LC-MS Studies
Immunoassays
Other Large Molecule Tests
Based Application, the North America market is segmented into the following sub-markets with annual revenue ($mn) for 2021-2031 included in each section.
Bioavailability and Bioequivalence Studies
Pharmacokinetics (PK)
Pharmacodynamics (PD)
Absorption, Distribution, Metabolism, Excretion (ADME)
Other Applications
By Test Type, the North America market is segmented into the following sub-markets with annual revenue ($mn) for 2021-2031 included in each section.
Cell-based Assays
Bacterial Cell-based Assays
Viral Cell-based Assays
Virology Testing
In Vitro Virology Testing
In Vivo Virology Testing
Species-Specific Viral PCR Assays
Serology, Immunogenicity, and Neutralizing Antibodies (SINA)
Bacterial Serology, Immunogenicity, and Neutralizing Antibodies
Viral Serology, Immunogenicity, and Neutralizing Antibodies
Method Development Optimization and Validation (MDOV)
Biomarker Testing
Pharmacokinetic Testing
Other Test Types
By Workflow Process, the North America market is segmented into the following sub-markets with annual revenue ($mn) for 2021-2031 included in each section.
Sample Preparation
Protein Precipitation
Liquid-liquid Extraction (LLE)
Sample Analysis
Hyphenated Technique
Chromatographic Technique
Electrophoresis
Ligand Binding Assay
Mass Spectrometry
Nuclear Magnetic Resonance
Other Workflow Processes
By Therapeutic Area, the North America market is segmented into the following sub-markets with annual revenue ($mn) for 2021-2031 included in each section.
Oncology
Neurology
Infectious Diseases
Gastroenterology
Cardiology
Other Therapeutic Areas
By End User, the North America market is segmented into the following sub-markets with annual revenue ($mn) for 2021-2031 included in each section.
Pharma and Biopharma Companies
Contract Development and Manufacturing Organizations (CDMOs)
Contract Research Organizations (CROs)
Selected Key Players:
Charles River Laboratories International Inc.
Covance Inc.
Eurofins Scientific
ICON PLC
Intertek Group PLC
IQVIA Holdings, Inc.
Laboratory Corporation of America Holdings
Medpace Holdings, Inc.
Pace Analytical Services LLC.
Parexel International Corporation
PPD Inc.
SGS SA
Syneos Health, LLC
Toxikon Corporation
WuXi Apptech Co., Ltd.
Key Topics Covered:
1 Introduction
2 Market Overview and Dynamics
3 Segmentation of North America Market by Molecule Type
4 Segmentation of North America Market by Application
5 Segmentation of North America Market by Test Type
6 Segmentation of North America Market by Workflow Process
7 Segmentation of North America Market by Therapeutic Area
8 Segmentation of North America Market by End User
9 North America Market 2021-2031 by Country
10 Competitive Landscape
For more information about this report visit https://www.researchandmarkets.com/r/xl5taj
Attachment
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900